AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/116
EFFECT OF INTERFERON-ALPHA THERAPY ON BONE-MARROW FIBROSIS IN CHRONICMYELOGENOUS LEUKEMIA
Authors: WILHELM M BUESORAMOS C OBRIEN S PIERCE S KEATING M TALPAZ M KANTARJIAN HM
Citation: M. Wilhelm et al., EFFECT OF INTERFERON-ALPHA THERAPY ON BONE-MARROW FIBROSIS IN CHRONICMYELOGENOUS LEUKEMIA, Leukemia, 12(1), 1998, pp. 65-70
EARLY TREATMENT DECISIONS WITH INTERFERON-ALPHA THERAPY IN EARLY CHRONIC-PHASE CHRONIC MYELOGENOUS LEUKEMIA
Authors: SACCHI S KANTARJIAN HM SMITH TL OBRIEN S PIERCE S KORNBLAU S BERAN M KEATING MJ TALPAZ M
Citation: S. Sacchi et al., EARLY TREATMENT DECISIONS WITH INTERFERON-ALPHA THERAPY IN EARLY CHRONIC-PHASE CHRONIC MYELOGENOUS LEUKEMIA, Journal of clinical oncology, 16(3), 1998, pp. 882-889
AMRINONE AND AMIODARONE - SERIOUS CONFUSION IN THE INTRAVENOUS LINE
Authors: POLLAK PT PIERCE S COOKE C
Citation: Pt. Pollak et al., AMRINONE AND AMIODARONE - SERIOUS CONFUSION IN THE INTRAVENOUS LINE, Archives of internal medicine, 158(2), 1998, pp. 193-194
COMPARISON OF REFERRING AND TERTIARY CANCER CENTER PHYSICIANS DIAGNOSES IN PATIENTS WITH LEUKEMIA
Authors: DELIMA M ALBITAR M OBRIEN S PIERCE S KANTARJIAN H ANDREEFF M FAYAD L KEATING M ESTEY E
Citation: M. Delima et al., COMPARISON OF REFERRING AND TERTIARY CANCER CENTER PHYSICIANS DIAGNOSES IN PATIENTS WITH LEUKEMIA, The American journal of medicine, 104(3), 1998, pp. 246-251
COMPARISON OF ACUTE MYELOID-LEUKEMIA PATIENTS AT MD ANDERSON - 1982-1986 VS 1992-1996
Authors: HOFF PM PIERCE S ESTEY E
Citation: Pm. Hoff et al., COMPARISON OF ACUTE MYELOID-LEUKEMIA PATIENTS AT MD ANDERSON - 1982-1986 VS 1992-1996, Leukemia, 11(12), 1997, pp. 1997-1998
LONG-TERM FOLLOW-UP RESULTS OF ALPHA-INTERFERON-BASED REGIMENS IN PATIENTS WITH LATE CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA
Authors: SACCHI S KANTARJIAN HM OBRIEN S BERAN M KOLLER C PIERCE S KORNBLAU S ESTEY E KEATING MJ TALPAZ M
Citation: S. Sacchi et al., LONG-TERM FOLLOW-UP RESULTS OF ALPHA-INTERFERON-BASED REGIMENS IN PATIENTS WITH LATE CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA, Leukemia, 11(10), 1997, pp. 1610-1616
ASSOCIATION BETWEEN INCREASED BODY-MASS INDEX AND A DIAGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
Authors: ESTEY E THALL P KANTARJIAN H PIERCE S KORNBLAU S KEATING M
Citation: E. Estey et al., ASSOCIATION BETWEEN INCREASED BODY-MASS INDEX AND A DIAGNOSIS OF ACUTE PROMYELOCYTIC LEUKEMIA IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA, Leukemia, 11(10), 1997, pp. 1661-1664
BONE ANABOLIC EFFECTS OF PGE1 IN AGED, OVARIECTOMIZED RATS MEASURED BY DXA, PQCT AND HISTOLOGY
Authors: DELONG MA JEE W JANKOWSKY M SOEHNER M PIERCE S MA YF HARTKE J LUNDY M
Citation: Ma. Delong et al., BONE ANABOLIC EFFECTS OF PGE1 IN AGED, OVARIECTOMIZED RATS MEASURED BY DXA, PQCT AND HISTOLOGY, Journal of bone and mineral research, 12, 1997, pp. 494-494
COMPARING AN APPLE TO A FRUIT SALAD - REPLY
Authors: ESTEY E THALL PF PIERCE S KANTARJIAN H KEATING M
Citation: E. Estey et al., COMPARING AN APPLE TO A FRUIT SALAD - REPLY, Journal of clinical oncology, 15(8), 1997, pp. 3021-3022
TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA WITHOUT CYTARABINE
Authors: ESTEY E THALL PF PIERCE S KANTARJIAN H KEATING M
Citation: E. Estey et al., TREATMENT OF NEWLY-DIAGNOSED ACUTE PROMYELOCYTIC LEUKEMIA WITHOUT CYTARABINE, Journal of clinical oncology, 15(2), 1997, pp. 483-490
HEMOLYTIC TRANSFUSION REACTION DUE TO ANTI-TC-A
Authors: KOWALSKI MA PIERCE S EDWARDS RL ETHIRAJAN S RYAN K
Citation: Ma. Kowalski et al., HEMOLYTIC TRANSFUSION REACTION DUE TO ANTI-TC-A, Transfusion, 37(9), 1997, pp. 139-139
OBJECT IDENTIFICATION WITHOUT FOVEAL VISION - EVIDENCE FROM AN ARTIFICIAL SCOTOMA PARADIGM
Authors: HENDERSON JM MCCLURE KK PIERCE S SCHROCK G
Citation: Jm. Henderson et al., OBJECT IDENTIFICATION WITHOUT FOVEAL VISION - EVIDENCE FROM AN ARTIFICIAL SCOTOMA PARADIGM, Perception & psychophysics, 59(3), 1997, pp. 323-346
TEMPERAMENT, SOCIAL COMPETENCE, AND ADRENOCORTICAL ACTIVITY IN PRESCHOOLERS
Authors: GUNNAR MR TOUT K DEHAAN M PIERCE S STANSBURY K
Citation: Mr. Gunnar et al., TEMPERAMENT, SOCIAL COMPETENCE, AND ADRENOCORTICAL ACTIVITY IN PRESCHOOLERS, Developmental psychobiology, 31(1), 1997, pp. 65-85
REGULATION OF DORSAL AXIS FORMATION IN XENOPUS BY A NOVEL GSK-3 BINDING-PROTEIN
Authors: KIMELMAN D FARR H YOST C PIERCE S
Citation: D. Kimelman et al., REGULATION OF DORSAL AXIS FORMATION IN XENOPUS BY A NOVEL GSK-3 BINDING-PROTEIN, Developmental biology, 186(2), 1997, pp. 51-51
LONG-TERM FOLLOW-UP OF PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA TREATED AT THE UNIVERSITY-OF-TEXAS M.-D.-ANDERSON-CANCER-CENTER
Authors: ESTEY E DELIMA M STROM S PIERCE S FREIREICH EJ KEATING MJ
Citation: E. Estey et al., LONG-TERM FOLLOW-UP OF PATIENTS WITH NEWLY-DIAGNOSED ACUTE MYELOID-LEUKEMIA TREATED AT THE UNIVERSITY-OF-TEXAS M.-D.-ANDERSON-CANCER-CENTER, Cancer, 80(11), 1997, pp. 2176-2180
EFFECT OF DIAGNOSIS (REFRACTORY-ANEMIA WITH EXCESS BLASTS, REFRACTORY-ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION, OR ACUTE MYELOID-LEUKEMIA [AML]) ON OUTCOME OF AML-TYPE CHEMOTHERAPY
Authors: ESTEY E THALL P BERAN M KANTARJIAN H PIERCE S KEATING M
Citation: E. Estey et al., EFFECT OF DIAGNOSIS (REFRACTORY-ANEMIA WITH EXCESS BLASTS, REFRACTORY-ANEMIA WITH EXCESS BLASTS IN TRANSFORMATION, OR ACUTE MYELOID-LEUKEMIA [AML]) ON OUTCOME OF AML-TYPE CHEMOTHERAPY, Blood, 90(8), 1997, pp. 2969-2977
APPLICATION OF THE INTERNATIONAL SCORING SYSTEM FOR MYELODYSPLASIA TOM.D.-ANDERSON PATIENTS
Authors: ESTEY E KEATING M PIERCE S BERAN M
Citation: E. Estey et al., APPLICATION OF THE INTERNATIONAL SCORING SYSTEM FOR MYELODYSPLASIA TOM.D.-ANDERSON PATIENTS, Blood, 90(7), 1997, pp. 2843-2844
IMPLICATIONS OF POTENTIAL CURE IN ACUTE MYELOGENOUS LEUKEMIA - DEVELOPMENT OF SUBSEQUENT CANCER AND RETURN TO WORK
Authors: DELIMA M STROM SS KEATING M KANTARJIAN H PIERCE S OBRIEN S FREIREICH E ESTEY E
Citation: M. Delima et al., IMPLICATIONS OF POTENTIAL CURE IN ACUTE MYELOGENOUS LEUKEMIA - DEVELOPMENT OF SUBSEQUENT CANCER AND RETURN TO WORK, Blood, 90(12), 1997, pp. 4719-4724
THE OUTCOME OF FUO DURING INDUCTION THERAPY OF AML MDS/
Authors: DABAJA B KANTARJIAN H PIERCE S KEATING M ESTEY E
Citation: B. Dabaja et al., THE OUTCOME OF FUO DURING INDUCTION THERAPY OF AML MDS/, Blood, 90(10), 1997, pp. 3761-3761
REFRACTORY OR RELAPSED BURKITTS TYPE ADULT LYMPHOBLASTIC-LEUKEMIA (ALL) - CHARACTERISTICS AND OUTCOME WITH SALVAGE THERAPY
Authors: THOMAS D KANTARJIAN H OBRIEN S KEATING MJ KOLLER C BERAN M ESTEY E PIERCE S FREIREICH E
Citation: D. Thomas et al., REFRACTORY OR RELAPSED BURKITTS TYPE ADULT LYMPHOBLASTIC-LEUKEMIA (ALL) - CHARACTERISTICS AND OUTCOME WITH SALVAGE THERAPY, Blood, 90(10), 1997, pp. 3852-3852
REVIEW OF 43 PATIENTS (PTS) WITH ADULT LYMPHOBLASTIC-LEUKEMIA (ALL) IN RELAPSE AFTER INITIAL CR DURATION GREATER-THAN-2 YEARS - CHARACTERISTICS, RESPONSE AND OUTCOME WITH SALVAGE THERAPY
Authors: THOMAS D KANTARJIAN H KOLLER C OBRIEN S KEATING MJ BERAN M ESTEY E PIERCE S FREIREICH E
Citation: D. Thomas et al., REVIEW OF 43 PATIENTS (PTS) WITH ADULT LYMPHOBLASTIC-LEUKEMIA (ALL) IN RELAPSE AFTER INITIAL CR DURATION GREATER-THAN-2 YEARS - CHARACTERISTICS, RESPONSE AND OUTCOME WITH SALVAGE THERAPY, Blood, 90(10), 1997, pp. 3853-3853
SIGNIFICANCE OF C-MPL EXPRESSION IN PHILADELPHIA-CHROMOSOME (PH)-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA (CML)
Authors: KANTARJIAN H MANSHOURI PT ESTROV Z TALPAZ M OBRIEN S BERAN M PIERCE S ESTEY E KEATING M ALBITAR M
Citation: H. Kantarjian et al., SIGNIFICANCE OF C-MPL EXPRESSION IN PHILADELPHIA-CHROMOSOME (PH)-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA (CML), Blood, 90(10), 1997, pp. 4000-4000
FAVORABLE CYTOGENETIC GROUPS IN ACUTE MYELOID-LEUKEMIA (AML) DO NOT OVEREXPRESS C-MPL PROTEIN
Authors: ALBITAR M MANSHOURI T KANTARJIAN H KEATING M ESTROV Z FABER J FREIREICH E PIERCE S ESTEY E
Citation: M. Albitar et al., FAVORABLE CYTOGENETIC GROUPS IN ACUTE MYELOID-LEUKEMIA (AML) DO NOT OVEREXPRESS C-MPL PROTEIN, Blood, 90(10), 1997, pp. 273-273
IDENTIFICATION OF A RELATIVELY FAVORABLE GROUP WITHIN AML MDS PTS WITH CHROMOSOME-5 AND/OR 7 ABNORMALITIES/
Authors: RAVANDI F KEATING M PIERCE S ESTEY E
Citation: F. Ravandi et al., IDENTIFICATION OF A RELATIVELY FAVORABLE GROUP WITHIN AML MDS PTS WITH CHROMOSOME-5 AND/OR 7 ABNORMALITIES/, Blood, 90(10), 1997, pp. 279-279
BETA-2-MICROGLOBULIN (B2M) IS A SIGNIFICANT PROGNOSTIC FACTOR FOR OUTCOME OF PATIENTS (PTS) WITH NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA(AML) AND MYELODYSPLASTIC SYNDROME (MDS)
Authors: CORTES J KANTARJIAN H KEATING M OBRIEN S RODRIGUEZ J PIERCE S ESTEY E
Citation: J. Cortes et al., BETA-2-MICROGLOBULIN (B2M) IS A SIGNIFICANT PROGNOSTIC FACTOR FOR OUTCOME OF PATIENTS (PTS) WITH NEWLY-DIAGNOSED ACUTE MYELOGENOUS LEUKEMIA(AML) AND MYELODYSPLASTIC SYNDROME (MDS), Blood, 90(10), 1997, pp. 285-285
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>